Who owns Urogen Pharma?
- Ticker: URGN
- CUSIP Number: m96088105
Tip: Access positions for across all investors
Analyze quarterly positions in Urogen Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Urogen Pharma stock
Who bought or sold Urogen Pharma this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 3.1M | $46M | 0% | Mar 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 2.6M | $39M | 0% | Mar 2024 |
|
| Menora Mivtachim Holdings | 2.3M | $35M | 0% | Mar 2024 |
|
| BlackRock | 1.7M | $26M | 43% | Mar 2024 |
|
| Cowen And Company | 1.6M | $24M | 100% | Mar 2024 |
|
| Adage Capital Partners GP | 1.3M | $20M | 100% | Mar 2024 |
|
| Credit Suisse | 1.2M | $18M | 0% | Mar 2024 |
|
| Point72 Asset Management | 1.1M | $17M | 783% | Mar 2024 |
|
| Leucadia National Corporation | 840k | $13M | 100% | Mar 2024 |
|
| Migdal Insurance & Financial Holdings | 687k | $10M | 6% | Mar 2024 |
|
| Harel Insurance Investments & Financial Services | 674k | $10M | -23% | Mar 2024 |
|
| Morgan Stanley | 391k | $6.6M | 251% | Mar 2024 |
|
| Geode Capital Management | 324k | $4.9M | 48% | Mar 2024 |
|
| Superstring Capital Management | 288k | $4.3M | 13% | Mar 2024 |
|
| Opaleye Management | 270k | $4.1M | -16% | Mar 2024 |
|
| T. Rowe Price Associates | 267k | $4.0M | 100% | Mar 2024 |
|
| Laurion Capital Management | 251k | $3.8M | 0% | Mar 2024 |
|
| Northern Trust | 233k | $3.5M | 31% | Mar 2024 |
|
| Wells Fargo & Company | 212k | $3.2M | -3% | Mar 2024 |
|
| Vanguard Group | 195k | $2.9M | 14% | Mar 2024 |
|
| Parkman Healthcare Partners | 184k | $2.8M | 27% | Mar 2024 |
|
| ARK Investment Management | 146k | $2.2M | -9% | Mar 2024 |
|
| AlphaCentric Advisors | 144k | $2.2M | -13% | Mar 2024 |
|
| Goldman Sachs Group | 114k | $1.7M | 0% | Mar 2024 |
|
| Citadel Advisors | 112k | $1.7M | -38% | Mar 2024 |
|
| Wellington Management Company | 105k | $1.6M | 49% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 104k | $1.6M | -21% | Mar 2024 |
|
| Nuveen Asset Management | 83k | $1.3M | 31% | Mar 2024 |
|
| Annandale Capital | 82k | $1.2M | 0% | Dec 2023 |
|
| Two Sigma Investments | 81k | $1.2M | -38% | Mar 2024 |
|
| Susquehanna International | 79k | $1.2M | 50% | Mar 2024 |
|
| De Lisle Partners | 77k | $1.2M | 100% | Mar 2024 |
|
| Cibc World Markets | 75k | $1.1M | 100% | Mar 2024 |
|
| Ameriprise Financial | 71k | $1.1M | -18% | Mar 2024 |
|
| Rice Hall James & Associates | 70k | $1.1M | 1% | Mar 2024 |
|
| Bank of New York Mellon | 68k | $1.0M | -3% | Mar 2024 |
|
| Squarepoint Ops | 63k | $946k | 6% | Mar 2024 |
|
| Charles Schwab Investment Management | 63k | $943k | 0% | Mar 2024 |
|
| Oak Ridge Investments | 61k | $918k | 100% | Mar 2024 |
|
| Bank of America Corporation | 53k | $796k | -26% | Mar 2024 |
|
| UBS Group | 43k | $643k | 71% | Mar 2024 |
|
| AQR Capital Management | 42k | $634k | 130% | Mar 2024 |
|
| Millennium Management | 42k | $628k | -90% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 40k | $597k | 73% | Mar 2024 |
|
| LLBH Private Wealth Management | 37k | $555k | -2% | Mar 2024 |
|
| HPM Partners | 37k | $555k | -70% | Mar 2024 |
|
| Meitav Dash Investments | 37k | $552k | -60% | Mar 2024 |
|
| Rhumbline Advisers | 37k | $552k | 6% | Mar 2024 |
|
| Robert Bender & Associates | 35k | $521k | 0% | Mar 2024 |
|
| Jump Financial | 33k | $500k | 13% | Dec 2023 |
|
| Shikiar Asset Management | 33k | $499k | 0% | Mar 2024 |
|
| TD Asset Management | 33k | $492k | 100% | Mar 2024 |
|
| Toroso Investments | 28k | $425k | 100% | Mar 2024 |
|
| BBR Partners | 26k | $390k | 0% | Mar 2024 |
|
| Balyasny Asset Management | 25k | $375k | 100% | Mar 2024 |
|
| Palo Alto Investors | 25k | $368k | 0% | Mar 2024 |
|
| Jane Street | 22k | $336k | 35% | Mar 2024 |
|
| Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet | 22k | $327k | 0% | Mar 2024 |
|
| Vivaldi Capital Management | 20k | $256k | 22% | Mar 2024 |
|
| Barclays | 19k | $291k | -48% | Mar 2024 |
|
| Two Sigma Advisers | 19k | $282k | 3% | Mar 2024 |
|
| Jpmorgan Chase & Co | 18k | $265k | -26% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 16k | $243k | -65% | Mar 2024 |
|
| GSA Capital Partners | 15k | $224k | 100% | Mar 2024 |
|
| MetLife Investment Advisors | 15k | $219k | 41% | Dec 2023 |
|
| American International | 14k | $203k | 38% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 13k | $196k | 26% | Mar 2024 |
|
| Engineers Gate Manager | 13k | $190k | 100% | Mar 2024 |
|
| Federated Investors | 12k | $176k | -11% | Dec 2023 |
|
| Royal Bank of Canada | 12k | $174k | -44% | Mar 2024 |
|
| Ethos Financial Group | 11k | $158k | 0% | Mar 2024 |
|
| Soleus Capital Management | 10k | $150k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 8.9k | $134k | 4% | Mar 2024 |
|
| Cubist Systematic Strategies | 6.2k | $92k | 4231% | Mar 2024 |
|
| China Universal Asset Management | 5.9k | $89k | 65% | Mar 2024 |
|
| Allspring Global Investments Holdings | 5.0k | $74k | 0% | Mar 2024 |
|
| Citigroup | 4.8k | $73k | -74% | Mar 2024 |
|
| FMR | 3.2k | $49k | -34% | Mar 2024 |
|
| Summit Investment Advisors | 2.8k | $42k | 0% | Mar 2024 |
|
| Simplex Trading | 2.8k | $42k | -58% | Mar 2024 |
|
| California State Teachers Retirement System | 2.8k | $42k | -35% | Mar 2024 |
|
| Legal & General Group | 2.8k | $42k | -3% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.6k | $24k | 47% | Dec 2023 |
|
| First Manhattan | 1.5k | $23k | 50% | Mar 2024 |
|
| Public Employees' Retirement Association of Colorado | 1.4k | $21k | -88% | Mar 2024 |
|
| Amalgamated Bank | 943.00 | $14k | -71% | Mar 2024 |
|
| Advisor Group Holdings | 663.00 | $9.9k | 0% | Mar 2024 |
|
| Signature | 650.00 | $9.8k | 6% | Mar 2024 |
|
| Pnc Financial Services | 543.00 | $8.1k | 54200% | Mar 2024 |
|
| Atlantic Trust | 509.00 | $7.2k | 100% | Mar 2024 |
|
| Nbc Securities | 437.00 | $6.0k | 100% | Mar 2024 |
|
| Lazard Asset Management | 354.00 | $5.0k | -89% | Dec 2023 |
|
| Russell Investments | 253.00 | $3.8k | 0% | Mar 2024 |
|
| Tower Research Capital | 187.00 | $2.8k | -98% | Mar 2024 |
|
| Lindbrook Capital | 160.00 | $2.4k | 158% | Mar 2024 |
|
| Us Bancorp | 134.00 | $2.0k | 0% | Mar 2024 |
|
| EverSource Wealth Advisors | 57.00 | $855.000000 | 0% | Mar 2024 |
|
| SYSTM Wealth Solutions | 48.00 | $720.000000 | 100% | Mar 2024 |
|
| Daiwa Securities Group | 48.00 | $999.998400 | 0% | Mar 2024 |
|
| CWM | 41.00 | $999.998200 | 100% | Mar 2024 |
|
| Quadrant Capital | 26.00 | $390.000000 | -54% | Mar 2024 |
|
| GAMMA Investing | 20.00 | $300.000000 | 100% | Mar 2024 |
|
| NISA Investment Advisors | 17.00 | $255.000000 | 100% | Mar 2024 |
|
| Farther Finance Advisors | 6.00 | $85.000200 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 4.00 | $60.000000 | 100% | Mar 2024 |
|
Who sold out of Urogen Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Clal Insurance Enterprises Holdings | Sep 2023 | 222k | $3.1M |
| Eudaimonia Asset Management | Sep 2023 | 171k | $2.4M |
| D. E. Shaw & Co | Dec 2023 | 78k | $1.2M |
| Marshall Wace | Dec 2023 | 29k | $428k |
| Walleye Trading Advisors | Dec 2023 | 27k | $408k |
| Verition Fund Management | Sep 2023 | 17k | $238k |
| Partners Capital Investment Group | Dec 2023 | 15k | $231k |
| Sierra Summit Advisors | Dec 2023 | 15k | $218k |
| Mirae Asset Global Investments | Dec 2023 | 11k | $170k |
| SG Americas Securities | Dec 2023 | 8.7k | $131k |
| Acadian Asset Management | Sep 2023 | 4.6k | $63k |
| Cutler | Dec 2023 | 1.6k | $5.0k |